Treatment of refractory vasospastic angina complicated by acute pulmonary oedema with levosimendan: A case report

Research output: Contribution to journalArticlepeer-review

Abstract

Background Vasospastic angina (VA) is an important cause of chest pain and patients often have 3- to 6-month clusters of recurrent attacks, separated by relatively asymptomatic periods. During these episodes the resulting myocardial ischaemia can lead to clinical complications of different severity, including acute myocardial infarction, acute heart failure, and cardiogenic shock. The management of severe and recurrent VA attacks is challenging, and no specific recommendations exist in recent cardiologic guidelines on the pharmacological strategy (inotropic/vasopressor agents) to adopt for this acute clinical setting. Case summary We present a case of recurrent episodes of VA complicated by acute pulmonary oedema and cardiogenic shock despite maximal tolerated therapy (intravenous calcium antagonist and nitrates) that was successfully treated with levosimendan. Discussion Levosimendan rapidly reverted cardiogenic shock, acute pulmonary oedema, and mitral regurgitation caused by a refractory coronary spasm, contributing to persistent clinical stabilization. Further evidence and a longer follow-up are needed to support our observation on the efficacy of levosimendan in this specific clinical setting.

Original languageEnglish
JournalEuropean Heart Journal - Case Reports
Volume3
Issue number1
DOIs
Publication statusPublished - Mar 1 2019

Keywords

  • Acute pulmonary oedema
  • Cardiogenic shock
  • Case report
  • Mitral regurgitation levosimendan
  • Vasospastic angina

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Treatment of refractory vasospastic angina complicated by acute pulmonary oedema with levosimendan: A case report'. Together they form a unique fingerprint.

Cite this